KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) EPS (Basic) (2016 - 2025)

West Pharmaceutical Services' EPS (Basic) history spans 17 years, with the latest figure at $1.83 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 2.23% year-over-year to $1.83; the TTM value through Dec 2025 reached $6.83, up 1.19%, while the annual FY2025 figure was $6.83, 1.19% up from the prior year.
  • EPS (Basic) for Q4 2025 was $1.83 at West Pharmaceutical Services, down from $1.94 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $2.53 in Q2 2022 and bottomed at $1.24 in Q1 2025.
  • The 5-year median for EPS (Basic) is $1.88 (2023), against an average of $1.92.
  • The largest annual shift saw EPS (Basic) surged 113.51% in 2021 before it crashed 31.65% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at $1.95 in 2021, then dropped by 29.23% to $1.38 in 2022, then soared by 34.06% to $1.85 in 2023, then fell by 3.24% to $1.79 in 2024, then rose by 2.23% to $1.83 in 2025.
  • Per Business Quant, the three most recent readings for WST's EPS (Basic) are $1.83 (Q4 2025), $1.94 (Q3 2025), and $1.82 (Q2 2025).